Checking for amyloidosis in trauma surgery patients
Part of Hormones & metabolism clinical trials.
This study is looking for people having planned trauma surgery to see if they have a hidden condition called amyloidosis. It may help find the disease early, especially in people with certain health risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (non-emergency) trauma surgery.
- You are 65 years or older, or have any of these warning signs: heart problems, family history of amyloidosis, nerve issues in hands or feet, or kidney/liver disease without a clear cause.
- You can follow study instructions and attend evaluations.
- You must sign a consent form (or have a legal representative sign for you).
- You must not have been previously diagnosed with amyloidosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often a specific type of heart condition (wild-type TTR cardiac amyloidosis) occurs in people whose nerve symptoms have no clear cause. The results may help doctors spot this treatable problem earlier when neuropathy is unexplained.
This trial is looking at leftover tissue from past spine surgeries to see if it contains signs of a heart condition called TTR amyloidosis. It may help find people who have this condition early.
This study looks at whether people having TAVR for aortic stenosis also have a condition called cardiac amyloidosis (abnormal protein buildup in the heart). If you're eligible, the study may help doctors detect this condition and better manage your care.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This research study checks a small sample of heart tissue during pacemaker or defibrillator placement to see if amyloidosis, a condition where abnormal proteins build up in organs, is present. It aims to find amyloidosis earlier so treatment can start sooner.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
Hear when a new Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.